Symposium 5

Symposium 5： Opportunities and Challenges for Chronic Airway Diseases

Chronic airway diseases, such as COPD, asthma and bronchiectasis were heterogeneous, complex, slowly developing diseases with varying phenotypes and rates of progression. These may range from mild disease with barely noticeable symptoms, to very severe disease with constant symptoms that greatly hinder the life of the patient. Guidelines issued by various medical societies provide guidance on how to diagnose and manage chronic airway diseases’ patients. It is now increasingly recognized that airway diseases management must be individualized, tailored not only to the severity of the disease but to the phenotypic characteristics of each patient. Each of these factors makes it exceedingly challenging to study and develop novel therapies. More opportunities and challenges need to find and overcome for managements of chronic airway diseases.